ION CHANNELS, TRANSPORTERS & CANCER
‘INCA 2015’

Day 1

9TH SEPTEMBER

0900-0945

REGISTRATION & COFFEE

0945-1000

Mustafa Djamgoz
Imperial College London, UK

WELCOME & INTRODUCTION

1000-1030
Frauke Alves
Goettingen, DE
Preclinical evaluation of cancer and their therapeutic concepts by non-invasive imaging in mouse models

1030-1100
Luis Pardo
Goettingen, DE
Cyclic expression of Kv10.1 potassium channel coordinates ciliogenesis with cell cycle exit

1100-1130
COFFEE & POSTERS

1130-1200
Annarosa Arcangeli
Florence, IT
hERG1 channels: role in the crosstalk between tumour cells and the tumour microenvironment

1200-1230
Antonio Felipe
Barcelona, SP
The voltage-dependent K+ channels Kv1.3 and Kv1.5 as cancer molecular markers

1230-1300
Ildiko Szabo
Padova, IT
Direct pharmacological targeting of a mitochondrial ion channel: in vivo studies


1300-1400
LUNCH & POSTERS

1400-1430
Gyorgy Panyi
Debrecen, H
The role of hEag1 in the mineral matrix production of SaOS-2 osteosarcoma cells

1430-1500
Sebastien Roger
Tours, FR
Voltage-gated sodium channels in the invasive properties of carcinoma cells

 1500-1530
William Brackenbury
York, UK
Targeting sodium channel-dependent breast cancer progression with phenytoin

1530-1600
TEA & POSTERS

1600-1630
Scott Fraser
Imperial College London, UK
Systems pathophysiology of voltage-gated sodium channel in breast cancer

1630-1700
Juan Carlos Gomora
Mexico City, MX
Voltage-gated sodium channels participation in the migration and invasiveness of cervical cancer

1730-1800
Tim Hales
Dundee, UK
Do direct effects of local anaesthetics on cancer cells improve prognosis after surgery?

1800-1815
COMFORT BREAK

1815-1930
Albrecht Schwab & Holger Kalthoff (Coordinators)
Munster & Kiel, DE
Special session: Pancreatic cancer: IonTraC Consortium Workshop

EVENING FREE

 Day 2

10TH September

0900-0930
Else Hoffman
Copenhagen, DK
Anion channels in proliferation, migration and apoptosis in cancer cells

0930-1000
Halima Ouadid-Ahidouch
Amiens, FR
TRPM7 channel and kinase activities: an attempt to unravel the impact of each component during cancer progression

1000-1030
David Beech
Leeds, UK
(-) Englerin A and TRPC4 in cancer

 1030-1100
COFFEE & POSTERS

1100-1130
Natalia Prevarskaya
Lille, FR
Calcium and calcium channels in initiation and progression of prostate cancer

1130-1200
Karen McCloskey
Belfast, UK
The impact of tumour environment conditions on functional expression on CaV1.3 and BK channels in prostate cancer

1200-1230
Ivana Novak
Copenhagen, CK
From pancreatic epithelial transport to pancreatic cancer

1230-1300
Stine Pedersen
Copenhagen, DK
Contributions from NBCn1, NHE1, MCT1 and -4 to mammary cancer tumour growth in vitro and in vivo

1300-1400
LUNCH & POSTERS

1400-1430
Pawel Sweitach
Oxford, UK
A passive pathway for venting metabolic acid from hypoxic tumour regions

1430-1500
Steve Reshkin
Bari, IT
The Na+/H+ exchanger (NHE1) is an essential component of the EGFR pathway in pancreatic ductal adenocarcinoma (PDAC) and is a new target for combination therapy

1500-1530
Diane Barber
UCSF, USA
Regulation of cancer cell behaviours by intracellular pH dynamics: From molecules to cells to tissues

1530-1400
TEA AND POSTERS

1600-1630
David Gorski
Karmanos Detroit, USA
Repurposing Riluzole as a treatment for breast cancer

 1630-1700
Arthur ‘Buzz’ Brown
Charles River (ChanTest),USA
Cancer drugs and cardiac risk

1700-1730
GENERAL DISCUSSION AND FUTURE PERSPECTIVES

1900

CONFERENCE DINNER

 

 

 

 

 

 

 ​










 

 

 

 

 •